How it unfolded
Just five months ago, the Forrester family’s life changed dramatically when two-year-old Leni Forrester was diagnosed with Sanfilippo disease, a rare genetic disorder often referred to as childhood dementia. This devastating condition progressively damages the brain, leading to severe cognitive and physical decline. The diagnosis has left her parents, Emily and Gus Forrester, grappling with the harsh reality of their daughter’s future.
Sanfilippo disease, which affects around 240 children born in the UK each year, is caused by an enzyme deficiency that prevents the body from breaking down certain molecules. As a result, children with this condition typically lose their ability to walk, talk, eat, and drink. The irreversible damage usually begins around the age of three, making early intervention crucial.
Emily Forrester describes the diagnosis as “every parent’s worst nightmare,” stating, “All your dreams for your child’s future are taken away.” The couple is now in a race against time to secure treatment for Leni, knowing that without it, she faces the prospect of suffering a profound decline and potentially dying in her early to mid-teens. “If we can’t get treatment, she will suffer the most awful physical and mental decline you can imagine and then die in her early to mid-teens,” Emily added, highlighting the urgency of their situation.
Currently, there are no approved treatments or cures for Sanfilippo disease in the UK, which has prompted the Forrester family to advocate for government funding for research into a clinical trial for potential treatment. They believe that early treatment is key, as damage cannot be reversed once it occurs. Their efforts are supported by Professor Brian Bigger, who has developed a gene therapy approach aimed at addressing childhood dementia.
The Forrester family is also calling for newborn screening to facilitate earlier detection of rare genetic conditions like Sanfilippo disease. With a 50 percent chance of being a carrier of the NAGLU gene, the couple emphasizes the need for proactive measures to identify affected children sooner, potentially improving their outcomes.
As Leni’s condition progresses, the urgency for action grows. The Forrester family’s plight underscores the broader issue of childhood dementia, which affects hundreds of families across the UK each year. Their advocacy not only seeks to secure treatment for Leni but also aims to raise awareness about the need for research and funding in this critical area.
As of now, the Forrester family remains hopeful yet anxious, navigating the complexities of a healthcare system that has yet to provide the solutions they desperately need. The clock is ticking, and every moment counts in their fight against childhood dementia.